BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7787774)

  • 1. Ascorbate/Fe(3+)-induced peroxidation and inhibition of the binding of A1 adenosine receptor ligands in rat brain membranes.
    Oliveira JC; Constantino MD; Sebastião AM; Ribeiro JA
    Neurochem Int; 1995 Mar; 26(3):263-8. PubMed ID: 7787774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the high affinity binding site for [3H]-1,3-dipropyl-8-cyclopentylxanthine in frog brain membranes.
    Oliveira JC; Sebastião AM; Ribeiro JA
    Br J Pharmacol; 1993 Jun; 109(2):518-23. PubMed ID: 8358551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binding of 1,3-[3H]-dipropyl-8-cyclopentylxanthine to adenosine A1 receptors in rat smooth muscle preparations.
    Peachey JA; Hourani SM; Kitchen I
    Br J Pharmacol; 1994 Dec; 113(4):1249-56. PubMed ID: 7889280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solubilized rat brain adenosine receptors have two high-affinity binding sites for 1,3-dipropyl-8-cyclopentylxanthine.
    Oliveira JC; Sebastião AM; Ribeiro JA
    J Neurochem; 1991 Oct; 57(4):1165-71. PubMed ID: 1895101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a low affinity binding site for N6-substituted adenosine derivatives in rat testis membranes.
    Mazzoni MR; Buffoni RS; Giusti L; Lucacchini A
    J Recept Signal Transduct Res; 1995; 15(7-8):905-29. PubMed ID: 8673723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of saponin on the binding and functional properties of the human adenosine A1 receptor.
    Cohen FR; Lazareno S; Birdsall NJ
    Br J Pharmacol; 1996 Apr; 117(7):1521-9. PubMed ID: 8730749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competition of adenine nucleotides for a 1,3-[3H]-dipropyl-8-cyclopentylxanthine binding site in rat vas deferens.
    Smith AD; Cheek DJ; Buxton IL; Westfall DP
    Clin Exp Pharmacol Physiol; 1997 Jul; 24(7):492-7. PubMed ID: 9248666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G protein coupling of CGS 21680 binding sites in the rat hippocampus and cortex is different from that of adenosine A1 and striatal A2A receptors.
    Cunha RA; Constantino MD; Ribeiro JA
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):295-302. PubMed ID: 10344528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists.
    Maemoto T; Finlayson K; Olverman HJ; Akahane A; Horton RW; Butcher SP
    Br J Pharmacol; 1997 Nov; 122(6):1202-8. PubMed ID: 9401787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of an adenosine A1 receptor agonist and adenosine A1 receptor antagonist to sheep pineal membranes.
    Falcón J; Privat K; Ravault JP
    Eur J Pharmacol; 1997 Oct; 337(2-3):325-31. PubMed ID: 9430432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible involvement of pertussis toxin-sensitive G proteins and D2 dopamine receptors in the A1 adenosine receptor-adenylate cyclase system in rat cerebral cortex.
    Murayama T; Itahashi Y; Nomura Y
    J Neurochem; 1990 Nov; 55(5):1631-8. PubMed ID: 2145396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
    Alexander SP; Curtis AR; Kendall DA; Hill SJ
    Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-dependent decrease in adenosine A1 receptor binding sites in the rat brain. Effect of cis unsaturated free fatty acids.
    Cunha RA; Constantino MD; Fonseca E; Ribeiro JA
    Eur J Biochem; 2001 May; 268(10):2939-47. PubMed ID: 11358511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic exposure to adenosine receptor agonists and antagonists reciprocally regulates the A1 adenosine receptor-adenylyl cyclase system in cerebellar granule cells.
    Hettinger-Smith BD; Leid M; Murray TF
    J Neurochem; 1996 Nov; 67(5):1921-30. PubMed ID: 8863496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermodynamics of full agonist, partial agonist, and antagonist binding to wild-type and mutant adenosine A1 receptors.
    Dalpiaz A; Townsend-Nicholson A; Beukers MW; Schofield PR; IJzerman AP
    Biochem Pharmacol; 1998 Dec; 56(11):1437-45. PubMed ID: 9827575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoradiographic visualization of A1 adenosine receptors in rat brain with [3H]8-cyclopentyl-1,3-dipropylxanthine.
    Weber RG; Jones CR; Lohse MJ; Palacios JM
    J Neurochem; 1990 Apr; 54(4):1344-53. PubMed ID: 2313291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A1 adenosine receptor-G protein coupling in bovine brain membranes: effects of guanine nucleotides, salt, and solubilization.
    Stiles GL
    J Neurochem; 1988 Nov; 51(5):1592-8. PubMed ID: 3139838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guanine nucleotide effects on 8-cyclopentyl-1,3-[3H]dipropylxanthine binding to membrane-bound and solubilized A1 adenosine receptors of rat brain.
    Klotz KN; Keil R; Zimmer FJ; Schwabe U
    J Neurochem; 1990 Jun; 54(6):1988-94. PubMed ID: 2338552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of adenosine A1 receptors in intact DDT1 MF-2 smooth muscle cells.
    Gerwins P; Nordstedt C; Fredholm BB
    Mol Pharmacol; 1990 Nov; 38(5):660-6. PubMed ID: 2172773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of A1 adenosine receptor ligand [3H]8-cyclopentyl-1,3-dipropylxanthine in coronary smooth muscle.
    Hussain T; Mustafa SJ
    Circ Res; 1995 Jul; 77(1):194-8. PubMed ID: 7788877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.